Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A6

    

• Editorials

  • ·Risk assessment in the genomic era: Are we missing the low-hanging fruit?

    Page :799-801

    Larry A. Allen, Christopher B. Granger

    Plan Plan
  • ·Getting real with drug-eluting stents: 5-year follow up of a real-world cohort

    Page :802-804

    Rahul Sakhuja, Deepak L. Bhatt

    Plan Plan

• Trial Design

  • ·Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

    Page :805

    Michael D. Ezekowitz, Stuart Connolly, Amit Parekh, Paul A. Reilly, Jeanne Varrone, Susan Wang, Jonas Oldgren, Ellison Themeles, Lars Wallentin, Salim Yusuf

    Résumé Résumé Plan Plan  
  • ·Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: Study design and rationale of a Korean multicenter prospective randomized trial

    Page :811

    Kyung Woo Park, Jung-Han Yoon, Jung-Sun Kim, Joo-Yong Hahn, Young-Seok Cho, In-Ho Chae, Hyeon-Cheol Gwon, Taehoon Ahn, Byung-Hee Oh, Jeong-Euy Park, Won-Heum Shim, Eak-Kyun Shin, Yang-Soo Jang, Hyo-Soo Kim

    Résumé Résumé Plan Plan  
  • ·Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the GRAVITAS trial

    Page :818

    Matthew J. Price, Peter B. Berger, Dominick J. Angiolillo, Paul S. Teirstein, Jean-François Tanguay, David E. Kandzari, Christopher P. Cannon, Eric J. Topol

    Résumé Résumé Plan Plan  

• Progress in Cardiology

  • ·New precompetitive paradigms: Focus on cardiac safety

    Page :825-826

    John Finkle, Daniel Bloomfield, Kathleen Uhl, Wendy Sanhai, Norman Stockbridge, Mitchell W. Krucoff

    
  • ·Assessing proarrhythmic potential of drugs when optimal studies are infeasible

    Page :827

    Edwin P. Rock, John Finkle, Howard J. Fingert, Brian P. Booth, Christine E. Garnett, Stephen Grant, Robert L. Justice, Richard J. Kovacs, Peter R. Kowey, Ignacio Rodriguez, Wendy R. Sanhai, Colette Strnadova, Shari L. Targum, Yi Tsong, Kathleen Uhl, Norman Stockbridge

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: Results from the Surgical Treatment for Ischemic Heart Failure trial

    Page :837

    Daniel B. Mark, J. David Knight, Eric J. Velazquez, Jonathan G. Howlett, John A. Spertus, Ljubomir T. Djokovic, Tina M. Harding, Gena R. Rankin, Laura A. Drew, Bozena Szygula-Jurkiewicz, Christopher Adlbrecht, Kevin J. Anstrom, for the Surgical Treatment for Ischemic Heart Failure (STICH) Trial Investigators

    Résumé Résumé Plan Plan  
  • ·Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

    Page :845-852

    Mark J. Sculpher, Greta Lozano-Ortega, Jennifer Sambrook, Stephen Palmer, Orges Ormanidhi, Ameet Bakhai, Marcus Flather, P. Gabriel Steg, Shamir R. Mehta, William Weintraub

    Résumé Résumé Plan Plan  
  • ·Physical activity restrictions for children after the Fontan operation: Disagreement between parent, cardiologist, and medical record reports

    Page :853-859

    Patricia E. Longmuir, Brian W. McCrindle

    Résumé Résumé Plan Plan
  • ·Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis

    Page :860-866

    Hasan Jilaihawi, Derek Chin, Mariuca Vasa-Nicotera, Mohamed Jeilan, Tomasz Spyt, G Andre Ng, Johan Bence, Elaine Logtens, Jan Kovac

    Résumé Résumé Plan Plan  
  • ·Percutaneous closure of patent foramen ovale and atrial septal defect in adults: The impact of clinical variables and hospital procedure volume on in-hospital adverse events

    Page :867-874

    Alexander R. Opotowsky, Michael J. Landzberg, Stephen E. Kimmel, Gary D. Webb

    Résumé Résumé Plan Plan
  • ·Doppler-derived preoperative mitral regurgitation volume predicts postoperative left ventricular dysfunction after mitral valve repair

    Page :875-882

    Tetsuhiro Yamano, A. Marc Gillinov, Nozomi Wada, Yoshiki Matsumura, Manatomo Toyono, James D. Thomas, Takahiro Shiota

    Résumé Résumé Plan Plan  
  • ·Real-time 3-dimensional echocardiography early after acute myocardial infarction: Incremental value of echo-contrast for assessment of left ventricular function

    Page :882.e1

    Gaetano Nucifora, Nina Ajmone Marsan, Eduard R. Holman, Hans-Marc J. Siebelink, Jacob M. van Werkhoven, Arthur J. Scholte, Ernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax

    Résumé Résumé Plan Plan  
  • ·Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice

    Page :883-888

    Jean-Jacques Goy, Philip Urban, Urs Kaufmann, Charles Seydoux, Edoardo De Benedetti, Alexandre Berger

    Résumé Résumé Plan Plan  
  • ·Aspirin noncompliance is the major cause of “aspirin resistance” in patients undergoing coronary stenting

    Page :889-893

    Thomas Cuisset, Corinne Frere, Jacques Quilici, Bénédicte Gaborit, Laurent Bali, Raphaël Poyet, Dorothée Faille, Pierre Emmanuel Morange, Marie-Christine Alessi, Jean-Louis Bonnet

    Résumé Résumé Plan Plan  
  • ·Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions

    Page :894-898

    Laurent Bonello, Axel De Labriolle, Gilles Lemesle, Daniel H. Steinberg, Probal Roy, Zhenyi Xue, Rebecca Torguson, Kimberley Kaneshige, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Joseph Lindsay, Ron Waksman

    Résumé Résumé Plan Plan  
  • ·The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents

    Page :899-907

    Michelle J. Butler, David Eccleston, David J. Clark, Andrew E. Ajani, Nick Andrianopoulos, Angela Brennan, Gishel New, Alexander Black, Gregory Szto, Chris M. Reid, Bryan P. Yan, James A. Shaw, Anthony M. Dart, Stephen J. Duffy, on behalf of the Melbourne Interventional Group (MIG)

    Résumé Résumé Plan Plan  
  • ·Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study

    Page :908-912

    Jung-Won Suh, Sang-Hong Baek, Jin-Shik Park, Hyun-Jae Kang, In-Ho Chae, Dong-Ju Choi, Hun-Jun Park, Pum-Joon Kim, Ki-Bae Seung, Hyo-Soo Kim

    Résumé Résumé Plan Plan  
  • ·Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial

    Page :913-918

    A. Selcuk Adabag, Salima Mithani, Basel Al Aloul, Dorothea Collins, Stefan Bertog, Hanna E. Bloomfield, for The Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

    Résumé Résumé Plan Plan  
  • ·Preoperative oral glucose tolerance testing in vascular surgery patients: Long-term cardiovascular outcome

    Page :919-925

    Jan-Peter van Kuijk, Martin Dunkelgrun, Frodo Schreiner, Willem-Jan Flu, Wael Galal, Ron T. van Domburg, Sanne E. Hoeks, Yvette R.B.M. van Gestel, Jeroen J. Bax, Don Poldermans

    Résumé Résumé Plan Plan  
  • ·Prospective assessment of the occurrence of anemia in patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry

    Page :926-932

    Kirkwood F. Adams, John H. Patterson, Ron M. Oren, Mandeep R. Mehra, Christopher M. O'Connor, Ileana L. Piña, Alan B. Miller, Jun R. Chiong, Stephanie H. Dunlap, William G. Cotts, Gary M. Felker, Douglas D. Schocken, Todd A. Schwartz, Jalal K. Ghali, for the STAMINA-HFP Registry Investigators

    Résumé Résumé Plan Plan  
  • ·Clinical correlates and prognostic significance of electrocardiographic abnormalities in apical ballooning syndrome (Takotsubo/stress-induced cardiomyopathy)

    Page :933-938

    Chadi Dib, Samuel Asirvatham, Ahmad Elesber, Charanjit Rihal, Paul Friedman, Abhiram Prasad

    Résumé Résumé Plan Plan  
  • ·Insulin resistance independently predicts the progression of coronary artery calcification

    Page :939-945

    Keane K. Lee, Stephen P. Fortmann, Joan M. Fair, Carlos Iribarren, Geoffrey D. Rubin, Ann Varady, Alan S. Go, Thomas Quertermous, Mark A. Hlatky

    Résumé Résumé Plan Plan  
  • ·Superior predictive ability for death of a basic metabolic profile risk score

    Page :946-954

    Heidi T. May, Benjamin D. Horne, Brianna S. Ronnow, Dale G. Renlund, Joseph B. Muhlestein, Donald L. Lappé, Robert R. Pearson, John F. Carlquist, Abdallah G. Kfoury, Tami L. Bair, Kismet D. Rasmusson, Jeffrey L. Anderson

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Atrial fibrillation and atherothrombosis: The importance of anticoagulation

    Page :e27

    Carlos Escobar, Vivencio Barrios

    
  • ·Response to “Atrial fibrillation and atherothrombosis: The importance of anticoagulation” by Escobar C and Barrios V

    Page :e29

    Shinya Goto, Deepak L. Bhatt, P. Gabriel Steg, on Behalf of the REACH Registry Investigators

    
  • ·Should African Americans be overtreated for depression the same as whites are? Commentary on Waldman et al (2009)

    Page :e31

    James C. Coyne, Peter de Jonge

    
  • ·More antidepressants for African Americans with coronary heart disease? Maybe—maybe not

    Page :e33

    Brett D. Thombs, Ademola B. Adeponle, Laurence J. Kirmayer, Cécile Rousseau, Roy C. Ziegelstein

    
  • ·Treating depression in patients with heart disease: Is the glass half empty or half full?

    Page :e35

    James A. Blumenthal, Silvina Waldman, Michael A. Babyak, Andrew Sherwood, Lana L. Watkins, Michael Sketch

    
  • ·Granulocyte-colony stimulating factor in refractory ischemic heart disease: Throwing stones from glass houses

    Page :e39

    Jason C. Kovacic, Peter Macdonald, Michael P. Feneley, Robert M. Graham

    
  • ·Response to letter to the editor by Kovacic et al

    Page :e41

    Timothy D. Henry, Daniel Satran, Robert F. Wilson